Want to join the conversation?
$CELG announced interim topline data from trial of investigational oral GED-0301 in patients with active Crohn's disease. Crohn's disease is an immune-mediated, chronic inflammatory condition of the gastrointestinal tract. The primary objective of the study is to explore the effect of GED-0301 on endoscopic outcomes.
$MON shares dip slightly; I wonder this is because of the environmental lawsuit filed by the Washington state against the production of PCBs.
My bet is that $FR will reach $32 in the short term. It’s time it broke the 52-week high and had its fair share of growth.
$WYNN got bruised up by China after its decision to cut withdrawal limit in Macau ATMs. Wynn Resorts shares went down by more than 11%! Well who could have guessed that right?